Abstract: NMEG-?CGRP, a biologically active molecule, and systems and methods of use therefore, subcutaneous administration of NMEG-?CGRP, a non-toxic peptoid-peptide hybrid that possesses hypotensive action, employed as a therapeutic agent to treat and prevent various cardiovascular diseases, including, heart failure (pressure. as well as volume, overload), myocardial infarction, cardiomyopathy, and hypertension.

Abstract: Methods and systems for delivering a very potent vasodilator that has the ability to treat and prevent heart failure including delivering microcapsules containing ?-CGRP, which show no toxicity and lowers blood pressure similar to the native peptide, where this new compound could greatly enhance the lifespan of patients suffering from heart failure.

Abstract: Use of metformin in inhibition of growth and/or viability of human neuroblastoma cells is described. Use of metformin in inhibition of growth and/or viability of neuroblastoma cancer stem cells is also described. The metformin is shown to be effective both in vitro and in vivo in inhibition of growth and/or viability of neuroblastoma cells of multiple different genetic backgrounds.

Abstract: Use of sparstolonin B in inhibition of growth and/or viability of human neuroblastoma cells is described. The sparstolonin B can be naturally derived from the Chinese herb Sparganium stoloniferum or can be synthetic. The sparstolonin B is shown to be effective both in vitro and in vivo in inhibition of growth and/or viability of neuroblastoma cells of multiple different genetic backgrounds including N-myc amplified with wild p53 neuroblastoma cells, N-myc amplified with mutated p53 neuroblastoma cells, and N-myc nonamplified neuroblastoma cells.

Abstract: Use of sparstolonin B in inhibition of growth and/or viability of human neuroblastoma cells is described. The sparstolonin B can be naturally derived from the Chinese herb Sparganium stoloniferum or can be synthetic. The sparstolonin B is shown to be effective both in vitro and in vivo in inhibition of growth and/or viability of neuroblastoma cells of multiple different genetic backgrounds including N-myc amplified with wild p53 neuroblastoma cells, N-myc amplified with mutated p53 neuroblastoma cells, and N-myc nonamplified neuroblastoma cells.

Abstract: A process and an apparatus for the preparation of petroleum hydrocarbon solvent with improved color stability from crude oils having high concentration of nitrogenous compounds which comprises passing said petroleum hydrocarbon stream containing substantial amount of nitrogenous compounds over a column of molecular sieves modified clays at ambient to elevated temperature and pressure maintaining the feed in the liquid state, thereby obtaining the petroleum hydrocarbon stream with desired color stability.

Abstract: A process and an apparatus for the preparation of petroleum hydrocarbon solvent with improved color stability from crude oils having high concentration of nitrogenous compounds which comprises passing said petroleum hydrocarbon stream containing substantial amount of nitrogenous compounds over a column of molecular sieves/modified clays at ambient to elevated temperature and pressure maintaining the feed in the liquid state, thereby obtaining the petroleum hydrocarbon stream with desired color stability.